Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|171|4|566-573

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.171, Iss.4, 2015-11, pp. : 566-573

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preventive antibiotics in pediatric patients with acute myeloid leukemia (AML)

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 7, 2015-07 ,pp. : 1149-1154

John Wiley & Sons Inc

Access to resources Recommend Favorite

Characteristics, clinical outcome, and prognostic significance of IDH mutations in AML

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 8, 2015-08 ,pp. : 732-736

John Wiley & Sons Inc

Access to resources Recommend Favorite

Approaches to Induction Therapy with Adult Acute Myeloid Leukaemia

By  

Acta Haematologica, Vol. 99, Iss. 3, 1998-04 ,pp. : 133-137

Karger

Access to resources Recommend Favorite

Posaconazole for primary antifungal prophylaxis in patients with acute myeloid leukaemia or myelodysplastic syndrome during remission induction chemotherapy: a single‐centre retrospective study in Korea and clinical considerations

By  

MYCOSES (ELECTRONIC), Vol. 58, Iss. 9, 2015-09 ,pp. : 565-571

John Wiley & Sons Inc

Access to resources Recommend Favorite

Advanced acute myelogenous leukaemia (AML) during HAART-treated HIV disease, manifesting initially as a thyroid mass

By Manfredi Roberto   Sabbatani Sergio   Chiodo Francesco  

Scandinavian Journal of Infectious Diseases, Vol. 37, Iss. 10, 2005-10 ,pp. : 781-783

Informa Healthcare

Access to resources Recommend Favorite